These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2532749)

  • 21. Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.
    Brooks DP; Contino LC; Trizna W; Edwards RM; Ohlstein EH; Solleveld HA
    J Pharmacol Exp Ther; 1990 Apr; 253(1):119-23. PubMed ID: 2139468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists.
    Ge ZD; Auchampach JA; Piper GM; Gross GJ
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):481-8. PubMed ID: 12605028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret.
    Gomoll AW; Ogletree ML
    Prostaglandins; 1993 Sep; 46(3):233-42. PubMed ID: 8234831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
    Yoo J; Schlondorff D; Neugarten J
    J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
    Smith EF; McDonald J
    Pharmacology; 1988; 36(5):340-7. PubMed ID: 3406046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
    Tsao PS; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
    Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
    Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
    Shimizu M; Wang QD; Sjöquist PO; Rydén L
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
    Fiedler VB; Seuter F; Perzborn E
    Stroke; 1990 Dec; 21(12 Suppl):IV149-51. PubMed ID: 2260140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size.
    Kapur NK; Paruchuri V; Urbano-Morales JA; Mackey EE; Daly GH; Qiao X; Pandian N; Perides G; Karas RH
    Circulation; 2013 Jul; 128(4):328-36. PubMed ID: 23766351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.
    Kolh P; Rolin S; Tchana-Sato V; Pétein M; Ghuysen A; Lambermont B; Hanson J; Magis D; Segers P; Masereel B; D'Orio V; Dogne JM
    Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):53-73. PubMed ID: 16516810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Auchampach JA; Pieper GM; Cavero I; Gross GJ
    Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
    Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
    Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).
    Schrör K; Thiemermann C
    Br J Pharmacol; 1986 Apr; 87(4):631-7. PubMed ID: 3011166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.